查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1861747

冠狀動脈繞道手術手術市場（依移植類型、手術類型、最終用戶和應用分類）－2025-2032年全球預測

Coronary Artery Bypass Grafts Market by Graft Type, Procedure Type, End User, Application - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，冠狀動脈繞道手術手術市場將成長至 297.6 億美元，複合年成長率為 6.36%。

關鍵市場統計數據
基準年 2024 181.6億美元
預計年份：2025年 193.2億美元
預測年份 2032 297.6億美元
複合年成長率 (%) 6.36%

全面概述目前冠狀動脈繞道手術手術的現狀，重點在於臨床發展、技術應用以及對醫療服務提供者的營運影響。

本執行摘要簡要介紹了現代冠狀動脈繞道手術手術（CABG）的生態系統，概述了正在重塑醫療服務模式的技術、臨床和營運因素。過去十年，影像學、血管獲取和手術全期管理的進步改變了臨床路徑，而手術範圍的不斷擴大也帶來了新的技能要求、資金規劃考量和患者選擇模式。

臨床團隊正日益努力平衡傳統開放性手術與微創手術，旨在縮短恢復時間並減少資源消耗。同時，醫院和專科中心也在重新思考其專案結構，以適應機器人手術、內視鏡器械和專用混合手術室的引入。這些變化正在影響著各機構的人員配置模式、訓練課程和資金分配決策。

此外，接受冠狀動脈繞道手術的患者群體正在發生變化，人口統計學特徵和合併症情況會影響移植血管的選擇和手術全期策略。因此，相關人員必須整合臨床證據、技術能力和操作可行性，以設計永續的治療路徑。本導言旨在引導讀者檢驗後續章節，這些章節將探討不斷變化的現狀、政策影響、細分市場資訊、區域趨勢、競爭定位，並為希望改善冠狀動脈繞道手術旁路移植術治療方法的領導者提供實用建議。

快速的臨床創新、外科手術多樣化和供應鏈協作如何重塑冠狀動脈再灌注治療路徑和機構優先事項

冠狀動脈繞道手術手術的格局正因技術創新、器材小型化和跨學科診療模式的進步而改變。新興技術正在縮小傳統開放性手術與微創手術之間的差距，促使許多醫療機構重新思考臨床路徑，並將縮短復健時間和減少醫院資源消耗作為優先事項。

同時，手術方式的多樣化正在影響醫療團隊建設和臨床核准政策。隨著微創內視鏡和機器人輔助技術與非體外循環和傳統體外循環技術日益普及，醫療機構面臨雙重挑戰：既要投資於模擬培訓和指導，又要維持必要的病例量以保持專業水平。這種情況促使心臟外科醫師、介入性心臟科醫師、麻醉師和手術全期團隊之間加強合作，以最佳化患者預後。

供應鏈創新和供應商合作也正在影響科技的普及進程。製造商提供整合系統和服務模式，降低了小型專案的進入門檻，而報銷環境和醫院資源限制則影響技術的普及時間。同時，患者對以患者為中心的照護期望不斷提高，這促使醫療機構採用循證通訊協定，以在不影響長期移植血管通暢性的前提下加速患者康復。這些因素共同作用，正在重新定義醫療機構在整個護理過程中提供冠狀動脈重組手術的方式。

評估2025年美國關稅變化對移植材料供應、醫療設備採購和供應鏈韌性的累積營運和採購影響

2025年政策和貿易發展引入的關稅調整對冠狀動脈繞道手術移植術相關技術的採購、製造和分銷管道產生了連鎖反應。這些政策措施顯著影響了用於移植準備和輸送系統的進口器材、專用設備和組件的成本結構，迫使許多供應鏈相關人員重新評估其採購和庫存策略。

因此，採購團隊越來越重視供應商多元化，並加強與區域製造業夥伴關係，以降低跨國政策波動帶來的風險。臨床負責人則與供應鏈負責人合作，選擇臨床等效的替代方案，並檢驗不同設備之間的互通性，以確保手術流程的連續性。同時，供應商合約談判也日趨複雜，更加關注總體擁有成本條款、服務水準協議以及應對海關延誤的方案。

在營運方面，一些醫療機構已加快對可重複使用器械的投資（在臨床適用的情況下），並提高了消毒能力以抵消前置作業時間帶來的風險。監管合規和品質保證團隊也在供應商選擇中發揮了更重要的作用，以確保替代供應商能夠滿足臨床績效預期。最終，貿易政策變化帶來的綜合影響凸顯了健全的籌資策略的重要性，以及臨床、供應鏈和商業相關人員之間密切合作的必要性。

針對性細分分析展示了移植類型、手術技術、臨床環境和臨床應用如何影響臨床和操作決策。

細分分析揭示了不同移植類型、手術技術、終端使用者環境和應用領域所帶來的獨特的臨床和採購影響，每種類型都有其獨特的操作和實施考量。檢驗不同移植類型之間的差異可知，當長期通暢性是首要考慮因素時，動脈移植往往是首選的手術技術；而靜脈移植則在某些特定的解剖和臨床情況下佔據主導地位，這會影響庫存組合和外科醫生培訓的重點。

手術方式的多樣性進一步增加了推廣應用的複雜性：儘管傳統心肺體外迴圈因其操作人員的廣泛熟練度和可預測的工作流程，仍然是許多醫療機構的基礎，但非心肺體外迴圈技術正被用於某些特定患者群體，以減輕心肺體外迴圈相關的後遺症。微創策略，包括內視鏡取骨和機器人輔助手術，正在向擁有先進設備和專業圍手術全期團隊的中心推廣，這需要對培訓、模擬和手術安排進行投入。

終端使用者細分突顯了門診手術中心、心臟中心和醫院之間不同的營運需求。門診機構優先考慮吞吐量、快速復健通訊協定和精益庫存管理模式，而專科心臟中心則專注於高度緊急的醫療服務組合和技術密集型手術。醫院必須在承擔急診護理職責的同時兼顧廣泛的外科手術病例，這需要靈活的供應合約和跨部門協作。應用主導的洞察能夠區分多支血管病變和單支血管病變，從而指導臨床路徑設計和移植血管選擇策略，因為冠狀動脈解剖結構複雜的患者通常需要多學科協作和資源密集的手術全期護理。總而言之，這些細分觀點指導著有針對性的專案設計和採購決策。

美洲、歐洲、中東和非洲以及亞太地區的區域趨勢正在影響招募模式、籌資策略和臨床專案設計。

區域趨勢將對美洲、歐洲、中東和非洲以及亞太地區的醫療程序組合、技術應用和供應鏈策略產生重大影響。在美洲，三級醫療中心和綜合醫療保健系統尤其重視技術應用，這些機構支持資本密集技術和結構化培訓計畫。這種環境有利於機器人技術和混合方法的快速試點，同時要求提供嚴格的臨床和營運效益證據。

歐洲、中東和非洲地區的區域差異導致了不同的應用模式。高所得國家的成熟心臟中心強調以結果為導向的應用，並輔以嚴格的法律規範；而新興市場則優先考慮能夠改善醫療服務可及性的可擴展解決方案。因此，供應商的合作策略必須進行調整，以適應報銷框架、區域臨床指南和基礎設施能力的差異。

亞太地區心臟外科手術的普及率差異顯著，多個市場正積極尋求擴大產能並推動心臟外科手術服務的現代化。製造商與當地經銷商之間的策略合作對於擴大先進設備和培訓的覆蓋範圍至關重要。在所有地區，人口趨勢、冠狀動脈疾病盛行率以及醫療保健系統組織結構的差異都會影響人力規劃、手術方案選擇和資本投資決策，因此需要針對特定市場採取臨床整合和商業化策略。

設備、機器人和服務供應商之間的競爭格局和策略行動將重新定義產品差異化和臨床夥伴關係。

冠狀動脈繞道手術手術生態系統的競爭動態反映了老牌外科器械製造商、新興機器人和影像處理公司以及提供全面支援的服務型供應商之間的相互作用。領先的器械製造商持續投資改善血管採集器械、吻合裝置和一次性耗材，旨在簡化工作流程並降低治療結果的差異性。同時，機器人和內視鏡系統正在革新傳統的手術室配置，並促進技術提供者和臨床中心之間就聯合開發和培訓計畫達成合作協議。

策略差異化越來越依賴整合硬體、耗材、數據分析和教育服務的捆綁式解決方案。能夠清晰展現縮短手術時間、改善病患復原指標、降低併發症發生率的供應商，正獲得更高的臨床認可度和偏好。同時，售後服務模式、遠端監控和外科醫生資格認證服務也為醫院提供了競爭優勢，因為醫院正在尋求可預測的性能和更低的生命週期成本。

醫療設備製造商與學術機構之間的合作有助於產生證據和進行真實世界檢驗，這反過來又為推廣應用和醫保報銷的討論奠定了基礎。供應鏈夥伴關係和區域製造地也為相關人員創造了競爭優勢，尤其是有助於確保跨區域供應的連續性和快速的服務回應。

為臨床和商業領導者提供切實可行的策略行動，以協調技術應用、採購彈性以及員工團隊發展，從而實現專案的永續成長。

產業領導者應優先考慮分階段、循證的技術採納方法，使臨床目標與營運能力和財務管理一致。首先，應進行多學科評估，包括手術量、外科醫生培訓需求和手術全期流程，以確定各機構在哪些領域投資微創或機器人手術能夠帶來最大的臨床和營運回報。儘早與臨床負責人、護理領導者和供應鏈合作夥伴合作，可確保制定實際的採納時間表，並為資格認證計畫提供支援。

其次，為降低營運風險，應尋求以靈活性、培訓支援和按績效付費服務協議為重點的供應商協議。如果存在關稅或政策相關的採購風險，則應透過多元化採購管道和探索區域製造夥伴關係關係來提高前置作業時間可靠性。為在確保患者安全的同時加快技能提升，應投資於模擬和指導項目，並整合強大的數據收集系統，以追蹤手術全期結果、資源利用情況和患者報告的康復指標。

最後，與支付方和監管機構建立合作關係，強調基於更快康復時間、更少併發症和最佳化治療路徑的價值提案。透過將嚴謹的臨床實踐與務實的採購和人力資源規劃相結合，領導者可以以創新且能顯著改善患者照護的方式，擴大先進冠狀動脈重組手術的規模。

本執行摘要的調查方法以證據為導向，結合了對臨床醫生的訪談、監管分析、文獻綜述和營運案例研究，以確保提供切實可行的見解。

本執行摘要的研究基於一項多方面方法論，旨在整合臨床證據、營運經驗和市場情報，同時保持分析的嚴謹性。主要研究包括對心臟外科醫生、循環系統護理師、其他醫療專業人員、採購人員和醫院管理人員進行結構化訪談，以收集第一線觀點對手術選擇、培訓限制和供應鏈優先事項的看法。這些定性研究結果與同行評審的臨床文獻、指南文件以及記錄手術結果和比較技術評估的註冊數據進行了三角驗證。

二次分析包括監管備案和醫療設備認證訊息，以了解產品生命週期和安全性概況，以及公共文件，以解讀採購和貿易趨勢。此外，實地案例研究探討了微創和機器人手術計畫的推廣路徑及其對資源分配、人員發展和手術量的影響。品質保證措施包括對訪談主題進行交叉檢驗、確保資料來源的調查方法透明化，以及由臨床領域專家進行同行評審，以確保解讀結果反映當前的實踐。

綜合來看，這些方法為本摘要中提出的研究結果和建議提供了結構化的、基於證據的基礎，重點在於操作適用性和臨床一致性。

一篇簡明扼要的綜述，重點介紹冠狀動脈再灌注治療領域在技術可行性、操作可行性和供應鏈穩定性之間取得平衡的實用進展。

總之，冠狀動脈繞道手術手術目前正處於務實演進階段，而非全面革新。微創技術、機器人技術和手術全期手術期通訊協定的進步正在拓展治療選擇，並為改善患者體驗創造機會，但培訓要求、資金限制和供應鏈考量等組織現實因素限制變革的步伐。

政策變化和關稅趨勢凸顯了建立穩健的採購體係以及臨床和供應鏈部門密切合作的重要性。細分市場分析表明，移植選擇、手術類型和臨床環境均需根據當地的臨床專長和基礎設施量身定做策略。不同地區的採用模式也強調了因地制宜、使技術應用與報銷體系、醫療衛生人力結構以及當地居民的醫療保健需求相契合的重要性。

對於正在經歷轉型期的組織而言，一條平衡的前進之路在於循序漸進的投資、嚴格的績效追蹤以及以服務、培訓和供應連續性為重點的策略性供應商合作。透過將臨床證據與營運規劃結合，醫療服務提供者和產業合作夥伴既可以改善患者療效，又能建立永續且面向未來的創新項目。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 擴大微創機器人輔助冠狀動脈繞道術的應用，旨在減輕患者的身體負擔和恢復時間。
  • 將先進的3D影像和擴增實境（AR）引導系統結合，以提高冠狀動脈旁路移植術（CABG）的精確度。
  • 擴大採用混合再灌注策略，將經皮冠狀動脈介入治療與擇期搭橋手術相結合，以實現最佳患者預後
  • 開發和臨床應用具有更高生物相容性和長期通暢性的生物工程血管移植物
  • 透過在高風險患者群體中推廣非體外迴圈冠狀動脈繞道手術移植術，最大限度地減少術中併發症和發病率
  • 抗菌和抗血栓塗層移植物材料的出現旨在降低術後感染和移植物阻塞率。
  • 透過實施術後復健促進通訊協定和遠端醫療監測，加快術後復健進程並降低再入院率。
  • 推廣微創內視鏡血管採集技術，以提高移植血管品質並減少供體部位併發症

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 依移植類型冠狀動脈繞道手術手術市場

  • 動脈
  • 靜脈

第9章 依手術方式冠狀動脈繞道手術手術市場

  • 常規泵浦上
  • 微創
    • 內視鏡
    • 機器人輔助
  • 非泵送

第10章 依最終用戶分類的冠狀動脈繞道手術手術市場

  • 門診手術中心
  • 心臟中心
  • 醫院

第11章 依應用分類的冠狀動脈繞道手術手術市場

  • 多支血管疾病
  • 單支血管病變

第12章冠狀動脈繞道手術手術市場（按地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章冠狀動脈繞道手術手術市場（按組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 各國冠狀動脈繞道手術手術市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Terumo Corporation
    • Medtronic plc
    • Getinge AB
    • LivaNova PLC
    • Edwards Lifesciences Corporation
    • B. Braun Melsungen AG
    • Baxter International Inc.
    • Teleflex Incorporated
    • CryoLife, Inc.
    • ConMed Corporation
Product Code: MRR-2A0283E2559F

The Coronary Artery Bypass Grafts Market is projected to grow by USD 29.76 billion at a CAGR of 6.36% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 18.16 billion
Estimated Year [2025] USD 19.32 billion
Forecast Year [2032] USD 29.76 billion
CAGR (%) 6.36%

A comprehensive orientation to the current coronary artery bypass graft environment highlighting clinical evolution, technology adoption, and operational implications for providers

This executive summary opens with a concise orientation to the contemporary coronary artery bypass graft ecosystem, framing the technological, clinical, and operational forces that are reshaping care delivery. Over the past decade, advances in imaging, conduit harvesting techniques, and perioperative management have altered clinical pathways, while procedural diversification has introduced new skill requirements, capital planning considerations, and patient selection paradigms.

Clinical teams are increasingly balancing traditional open techniques with less invasive approaches that aim to reduce recovery time and resource utilization. At the same time, hospitals and specialized centers are reassessing program structures to accommodate robotics, endoscopic instrumentation, and dedicated hybrid operating rooms. These shifts have implications for staffing models, training curricula, and capital allocation decisions across institutions.

Moreover, the patient population undergoing bypass procedures is evolving, with demographic trends and comorbidity profiles influencing graft selection and perioperative strategies. As a result, stakeholders must integrate clinical evidence, technology capability, and operational feasibility to design durable care pathways. The introduction prepares the reader to explore subsequent sections that examine landscape transformations, policy impacts, segmentation intelligence, regional dynamics, competitive positioning, and pragmatic recommendations for leaders aiming to refine their approach to coronary artery bypass graft care.

How rapid clinical innovations, procedural diversification, and supply chain partnerships are reshaping coronary revascularization pathways and institutional priorities

The coronary artery bypass graft landscape is undergoing transformative shifts driven by innovations in technique, device miniaturization, and multidisciplinary care models. Emerging technologies have narrowed the gap between traditional open surgery and less invasive strategies, prompting many centers to reevaluate clinical pathways to prioritize faster recoveries and reduced inpatient resource use.

Concurrently, procedural diversification is influencing workforce development and privileging policies. As minimally invasive endoscopic and robotic-assisted techniques gain traction alongside off-pump and conventional on-pump approaches, institutions face the dual challenge of ensuring procedural volume to maintain proficiency while investing in simulation and proctoring programs. This dynamic fosters collaborative relationships between cardiac surgeons, interventional cardiologists, anesthesiologists, and perioperative teams to optimize patient outcomes.

Supply chain innovation and vendor partnerships are also affecting adoption curves. Manufacturers are offering integrated systems and service models that lower the barrier to entry for smaller programs, while reimbursement environments and hospital resource constraints shape rollout timelines. In parallel, patient-centered care expectations-driven by shorter hospital stays and quicker return-to-function-are motivating providers to adopt evidence-informed protocols that support accelerated recovery without compromising long-term graft patency. Taken together, these shifts are redefining how institutions deliver coronary revascularization across the care continuum.

Assessing the cumulative operational and procurement consequences of United States tariff shifts in 2025 on graft supplies, device sourcing, and supply chain resilience

Policy and trade dynamics in 2025 introduced tariff changes that ripple across procurement, manufacturing, and distribution channels linked to coronary artery bypass graft technologies. These policy measures have had a pronounced effect on cost structures for imported instruments, specialized devices, and component materials used in graft preparation and delivery systems, prompting many supply chain stakeholders to reassess sourcing and inventory strategies.

As a consequence, procurement teams are increasingly emphasizing supplier diversification and regional manufacturing partnerships to mitigate exposure to cross-border policy volatility. Clinical leaders have responded by working with supply chain counterparts to identify clinically equivalent alternatives and to validate device interoperability to maintain procedural continuity. In parallel, contract negotiations with vendors have grown more intricate, with greater focus on total-cost-of-ownership clauses, service level agreements, and contingencies for customs-related delays.

Operationally, some institutions have accelerated investments in reusable instrumentation where clinically appropriate and enhanced sterilization capacity to offset lead-time risks. Regulatory compliance and quality assurance teams have also become more central to vendor selection, ensuring that alternative sources meet clinical performance expectations. Ultimately, the combined effect of trade policy shifts has underscored the importance of resilient procurement strategies and closer alignment between clinical, supply chain, and commercial stakeholders.

Targeted segmentation insights showing how graft type, procedure modality, care setting, and clinical application drive distinct clinical and operational decisions

Segmentation-based insights reveal differentiated clinical and procurement implications across graft types, procedure modalities, end-user settings, and applications, each carrying distinct operational and adoption considerations. When examining graft type distinctions, arterial conduits often command procedural preference where long-term patency is prioritized, whereas venous grafts remain a mainstay for specific anatomic and clinical scenarios, influencing inventory mix and surgeon training priorities.

Procedure type distinctions further nuance adoption pathways: conventional on-pump approaches anchor many institutional programs due to broad practitioner familiarity and predictable workflows, while off-pump techniques are leveraged in select populations to reduce cardiopulmonary bypass-related sequelae. Minimally invasive strategies, including endoscopic harvesting and robotic-assisted operations, are expanding into centers that can support advanced instrumentation and dedicated perioperative teams, and they necessitate coordinated investments in training, simulation, and case scheduling.

End-user segmentation underscores divergent operational requirements across ambulatory surgical centers, cardiac centers, and hospitals. Ambulatory facilities emphasize throughput, rapid recovery protocols, and lean inventory models, whereas specialized cardiac centers focus on high-acuity service portfolios and technology-intensive procedures. Hospitals balance both acute care responsibilities and broader surgical case mixes, requiring flexible supply agreements and cross-departmental coordination. Application-driven insights, differentiating multi-vessel disease from single-vessel disease, inform clinical pathway design and graft selection strategies, as patients with complex coronary anatomy often demand multi-disciplinary planning and resource-intensive perioperative care. These segmentation perspectives collectively guide targeted program design and procurement decisions.

Regional dynamics across the Americas, Europe Middle East and Africa, and Asia-Pacific that influence adoption patterns, procurement strategies, and clinical program design

Regional dynamics exert a strong influence on procedural mix, technology adoption, and supply chain strategies across the Americas, Europe Middle East and Africa, and Asia-Pacific geographies. In the Americas, there is a pronounced emphasis on innovation diffusion within tertiary centers and integrated health systems that can underwrite capital-intensive technologies and structured training programs. This environment supports rapid piloting of robotics and hybrid approaches while demanding rigorous evidence of clinical and operational benefit.

Across Europe, the Middle East and Africa, regional heterogeneity leads to varied adoption profiles; established cardiac centers in high-income countries emphasize outcomes-driven implementation with strong regulatory oversight, whereas emerging markets prioritize scalable solutions that improve access to care. Consequently, vendor engagement strategies must be adapted to account for reimbursement frameworks, local clinical guidelines, and variable infrastructure capabilities.

The Asia-Pacific region displays a broad spectrum of adoption velocities, with several markets actively pursuing capacity expansion and modernization of cardiac surgical services. Strategic partnerships between manufacturers and regional distributors have been pivotal in expanding access to advanced instruments and training. Across all regions, differences in demographic trends, prevalence of coronary disease, and health system organization shape workforce planning, procedural selection, and capital investment decisions, requiring market-specific approaches to clinical integration and commercialization.

Competitive landscape and strategic behaviors among device, robotics, and service providers that are redefining product differentiation and clinical partnerships

Competitive dynamics in the coronary artery bypass graft ecosystem reflect an interplay between established surgical device manufacturers, emerging robotics and imaging companies, and service-oriented vendors offering integrated support. Leading device firms continue to invest in iterative improvements to conduit harvesting tools, anastomotic devices, and disposables that aim to simplify workflows and reduce variability in outcomes. At the same time, robotics and endoscopic systems are disrupting traditional operating room configurations, prompting collaborative agreements between tech providers and clinical centers for co-development and training programs.

Strategic differentiation increasingly rests on bundled solutions that combine hardware, consumables, data analytics, and educational services. Vendors that demonstrate a clear pathway to reduce operating time, improve patient recovery metrics, or lower complication rates secure stronger clinical advocacy and preference. Meanwhile, aftermarket service models, remote monitoring, and surgeon credentialing offerings have become competitive levers as hospitals seek predictable performance and reduced lifecycle costs.

Partnerships between device manufacturers and academic centers facilitate evidence generation and real-world validation, which in turn informs adoption and reimbursement conversations. Supply chain partnerships and regional manufacturing footprints are also shaping competitive positioning, particularly for stakeholders aiming to ensure continuity of supply and responsive service across diverse geographies.

Practical strategic actions for clinical and commercial leaders to align technology adoption, procurement resilience, and workforce development for sustainable program growth

Industry leaders should prioritize a phased, evidence-driven approach to technology adoption that aligns clinical objectives with operational capacity and financial stewardship. Begin by conducting multidisciplinary assessments of procedure volumes, surgeon training needs, and perioperative pathways to identify which minimally invasive or robotic investments will yield the greatest clinical and operational returns for a given institution. Early engagement with clinical champions, nursing leadership, and supply chain partners ensures realistic implementation timelines and supports credentialing plans.

Next, pursue supplier agreements that emphasize flexibility, training support, and outcome-linked service commitments to mitigate operational risk. Where tariff- or policy-related procurement exposures exist, diversify sourcing and consider regional manufacturing partnerships to improve lead-time reliability. Invest in simulation and proctoring programs to accelerate proficiency while protecting patient safety, and integrate robust data collection to track perioperative outcomes, resource use, and patient-reported recovery metrics.

Finally, foster collaborative relationships with payers and regulatory stakeholders to highlight value propositions rooted in improved recovery times, reduced complications, and optimized care pathways. By combining clinical rigor with pragmatic procurement and workforce planning, leaders can scale advanced coronary revascularization approaches in a manner that balances innovation with measurable improvements in patient care.

An evidence-driven research methodology combining primary clinician interviews, regulatory analysis, literature review, and operational case studies to ensure actionable insights

The research underpinning this executive summary draws on a multi-method approach designed to synthesize clinical evidence, operational experience, and market intelligence while preserving analytical rigor. Primary research involved structured interviews with cardiac surgeons, perfusionists, allied health professionals, procurement directors, and hospital administrators to capture firsthand perspectives on procedural selection, training constraints, and supply chain priorities. These qualitative insights were triangulated with peer-reviewed clinical literature, guideline documents, and registries that document procedural outcomes and comparative technique evaluations.

Secondary analysis incorporated regulatory filings and device approvals to understand product lifecycles and safety profiles, alongside public policy materials that contextualize procurement and trade dynamics. Additionally, site-level case studies explored implementation pathways for minimally invasive and robotic programs, highlighting resource allocation, staff competency development, and throughput impacts. Quality assurance measures included cross-validation of interview themes, methodological transparency regarding data sources, and peer review by clinical subject-matter experts to ensure that interpretations reflect current practice realities.

Together, these methods provide a structured, evidence-informed basis for the insights and recommendations offered in this summary, with an emphasis on operational applicability and clinical integrity.

A concise synthesis emphasizing pragmatic evolution in coronary revascularization balancing technological promise with operational feasibility and supply chain stability

In conclusion, the coronary artery bypass graft environment is in a period of pragmatic evolution rather than wholesale replacement. Advances in minimally invasive techniques, robotics, and perioperative protocols are expanding therapeutic options and creating opportunities for improved patient experiences, while institutional realities such as training requirements, capital constraints, and supply chain considerations temper the pace of change.

Policy shifts and tariff dynamics have highlighted the importance of procurement resilience and closer collaboration between clinical and supply chain leadership. Segmentation insights demonstrate that graft selection, procedural modality, and care setting each demand tailored strategies that accommodate local clinical expertise and infrastructure. Regionally, diverse adoption patterns underscore the value of context-specific approaches that align technology deployment with reimbursement, workforce capacity, and population health needs.

For organizations seeking to navigate this transition, the balanced path forward involves phased investment, rigorous outcome tracking, and strategic supplier partnerships that emphasize service, training, and supply continuity. By synthesizing clinical evidence with operational planning, providers and industry partners can improve patient outcomes while building programs that are sustainable and responsive to future innovation.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Increasing adoption of minimally invasive robotic-assisted coronary artery bypass procedures to reduce patient trauma and recovery times
  • 5.2. Integration of advanced 3D imaging and augmented reality guidance systems for enhanced surgical precision in CABG operations
  • 5.3. Rising utilization of hybrid revascularization strategies combining percutaneous coronary interventions with selective bypass grafting for optimal patient outcomes
  • 5.4. Development and clinical adoption of bioengineered vascular grafts with improved biocompatibility and long-term patency rates
  • 5.5. Expansion of off-pump coronary artery bypass techniques in high-risk patient populations to minimize intraoperative complications and morbidity
  • 5.6. Emergence of antimicrobial and antithrombotic-coated graft materials aimed at reducing postoperative infections and graft occlusion rates
  • 5.7. Implementation of enhanced recovery after surgery protocols and telehealth monitoring to accelerate postoperative rehabilitation and reduce readmission
  • 5.8. Growth of minimally invasive endoscopic vessel harvesting methods to improve graft quality and decrease donor site complications

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Coronary Artery Bypass Grafts Market, by Graft Type

  • 8.1. Arterial
  • 8.2. Venous

9. Coronary Artery Bypass Grafts Market, by Procedure Type

  • 9.1. Conventional On Pump
  • 9.2. Minimally Invasive
    • 9.2.1. Endoscopic
    • 9.2.2. Robotic
  • 9.3. Off Pump

10. Coronary Artery Bypass Grafts Market, by End User

  • 10.1. Ambulatory Surgical Centers
  • 10.2. Cardiac Centers
  • 10.3. Hospitals

11. Coronary Artery Bypass Grafts Market, by Application

  • 11.1. Multi Vessel Disease
  • 11.2. Single Vessel Disease

12. Coronary Artery Bypass Grafts Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Coronary Artery Bypass Grafts Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Coronary Artery Bypass Grafts Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Terumo Corporation
    • 15.3.2. Medtronic plc
    • 15.3.3. Getinge AB
    • 15.3.4. LivaNova PLC
    • 15.3.5. Edwards Lifesciences Corporation
    • 15.3.6. B. Braun Melsungen AG
    • 15.3.7. Baxter International Inc.
    • 15.3.8. Teleflex Incorporated
    • 15.3.9. CryoLife, Inc.
    • 15.3.10. ConMed Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. CORONARY ARTERY BYPASS GRAFTS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. CORONARY ARTERY BYPASS GRAFTS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. CORONARY ARTERY BYPASS GRAFTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY ARTERIAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY ARTERIAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY ARTERIAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY ARTERIAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY ARTERIAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY ARTERIAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY VENOUS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY VENOUS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY VENOUS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY VENOUS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY VENOUS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY VENOUS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY CONVENTIONAL ON PUMP, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY CONVENTIONAL ON PUMP, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY CONVENTIONAL ON PUMP, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY CONVENTIONAL ON PUMP, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY CONVENTIONAL ON PUMP, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY CONVENTIONAL ON PUMP, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY ENDOSCOPIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY ENDOSCOPIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY ENDOSCOPIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY ENDOSCOPIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY ENDOSCOPIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY ENDOSCOPIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY ROBOTIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY ROBOTIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY ROBOTIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY ROBOTIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY ROBOTIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY ROBOTIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY OFF PUMP, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY OFF PUMP, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY OFF PUMP, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY OFF PUMP, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY OFF PUMP, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY OFF PUMP, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY CARDIAC CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY CARDIAC CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY CARDIAC CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY CARDIAC CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY CARDIAC CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY CARDIAC CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MULTI VESSEL DISEASE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MULTI VESSEL DISEASE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MULTI VESSEL DISEASE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MULTI VESSEL DISEASE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MULTI VESSEL DISEASE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MULTI VESSEL DISEASE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY SINGLE VESSEL DISEASE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY SINGLE VESSEL DISEASE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY SINGLE VESSEL DISEASE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY SINGLE VESSEL DISEASE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY SINGLE VESSEL DISEASE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY SINGLE VESSEL DISEASE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. AMERICAS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 90. AMERICAS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 91. AMERICAS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2024 (USD MILLION)
  • TABLE 92. AMERICAS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2025-2032 (USD MILLION)
  • TABLE 93. AMERICAS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 94. AMERICAS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 95. AMERICAS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 96. AMERICAS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 97. AMERICAS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 98. AMERICAS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 99. AMERICAS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 100. AMERICAS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 101. NORTH AMERICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. NORTH AMERICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2024 (USD MILLION)
  • TABLE 104. NORTH AMERICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2025-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 106. NORTH AMERICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 108. NORTH AMERICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 110. NORTH AMERICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 112. NORTH AMERICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. LATIN AMERICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2024 (USD MILLION)
  • TABLE 116. LATIN AMERICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2025-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 118. LATIN AMERICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 120. LATIN AMERICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 122. LATIN AMERICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 124. LATIN AMERICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2024 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2025-2032 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 137. EUROPE CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. EUROPE CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. EUROPE CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2024 (USD MILLION)
  • TABLE 140. EUROPE CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2025-2032 (USD MILLION)
  • TABLE 141. EUROPE CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 142. EUROPE CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 143. EUROPE CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 144. EUROPE CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 145. EUROPE CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 146. EUROPE CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 147. EUROPE CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 148. EUROPE CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. MIDDLE EAST CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. MIDDLE EAST CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2024 (USD MILLION)
  • TABLE 152. MIDDLE EAST CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2025-2032 (USD MILLION)
  • TABLE 153. MIDDLE EAST CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 154. MIDDLE EAST CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 156. MIDDLE EAST CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 157. MIDDLE EAST CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 158. MIDDLE EAST CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 159. MIDDLE EAST CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 160. MIDDLE EAST CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 161. AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2024 (USD MILLION)
  • TABLE 164. AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2025-2032 (USD MILLION)
  • TABLE 165. AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 166. AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 167. AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 168. AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 169. AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 170. AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 171. AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 172. AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 173. ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2024 (USD MILLION)
  • TABLE 176. ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2025-2032 (USD MILLION)
  • TABLE 177. ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 178. ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 179. ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 180. ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 181. ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 182. ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 183. ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 184. ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 187. ASEAN CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. ASEAN CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. ASEAN CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2024 (USD MILLION)
  • TABLE 190. ASEAN CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2025-2032 (USD MILLION)
  • TABLE 191. ASEAN CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 192. ASEAN CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 193. ASEAN CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 194. ASEAN CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 195. ASEAN CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 196. ASEAN CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 197. ASEAN CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 198. ASEAN CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 199. GCC CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. GCC CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. GCC CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2024 (USD MILLION)
  • TABLE 202. GCC CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2025-2032 (USD MILLION)
  • TABLE 203. GCC CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 204. GCC CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 205. GCC CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 206. GCC CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 207. GCC CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 208. GCC CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 209. GCC CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 210. GCC CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 211. EUROPEAN UNION CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 212. EUROPEAN UNION CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 213. EUROPEAN UNION CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2024 (USD MILLION)
  • TABLE 214. EUROPEAN UNION CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2025-2032 (USD MILLION)
  • TABLE 215. EUROPEAN UNION CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 216. EUROPEAN UNION CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 217. EUROPEAN UNION CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 218. EUROPEAN UNION CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 219. EUROPEAN UNION CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 220. EUROPEAN UNION CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 221. EUROPEAN UNION CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 222. EUROPEAN UNION CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 223. BRICS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 224. BRICS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 225. BRICS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2024 (USD MILLION)
  • TABLE 226. BRICS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2025-2032 (USD MILLION)
  • TABLE 227. BRICS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 228. BRICS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 229. BRICS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 230. BRICS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 231. BRICS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 232. BRICS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 233. BRICS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 234. BRICS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 235. G7 CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 236. G7 CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 237. G7 CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2024 (USD MILLION)
  • TABLE 238. G7 CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2025-2032 (USD MILLION)
  • TABLE 239. G7 CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 240. G7 CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 241. G7 CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 242. G7 CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 243. G7 CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 244. G7 CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 245. G7 CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 246. G7 CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 247. NATO CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 248. NATO CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 249. NATO CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2024 (USD MILLION)
  • TABLE 250. NATO CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2025-2032 (USD MILLION)
  • TABLE 251. NATO CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 252. NATO CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 253. NATO CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 254. NATO CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 255. NATO CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 256. NATO CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 257. NATO CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 258. NATO CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 261. UNITED STATES CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2024 (USD MILLION)
  • TABLE 262. UNITED STATES CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2025-2032 (USD MILLION)
  • TABLE 263. UNITED STATES CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 264. UNITED STATES CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 265. UNITED STATES CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 266. UNITED STATES CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 267. UNITED STATES CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 268. UNITED STATES CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 269. UNITED STATES CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 270. UNITED STATES CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 271. CANADA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2024 (USD MILLION)
  • TABLE 272. CANADA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2025-2032 (USD MILLION)
  • TABLE 273. CANADA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 274. CANADA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 275. CANADA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 276. CANADA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 277. CANADA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 278. CANADA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 279. CANADA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 280. CANADA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 281. MEXICO CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2024 (USD MILLION)
  • TABLE 282. MEXICO CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2025-2032 (USD MILLION)
  • TABLE 283. MEXICO CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 284. MEXICO CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 285. MEXICO CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 286. MEXICO CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 287. MEXICO CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 288. MEXICO CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 289. MEXICO CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 290. MEXICO CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 291. BRAZIL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2024 (USD MILLION)
  • TABLE 292. BRAZIL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2025-2032 (USD MILLION)
  • TABLE 293. BRAZIL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 294. BRAZIL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 295. BRAZIL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 296. BRAZIL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 297. BRAZIL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 298. BRAZIL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 299. BRAZIL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 300. BRAZIL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 301. UNITED KINGDOM CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2024 (USD MILLION)
  • TABLE 302. UNITED KINGDOM CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2025-2032 (USD MILLION)
  • TABLE 303. UNITED KINGDOM CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 304. UNITED KINGDOM CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 305. UNITED KINGDOM CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 306. UNITED KINGDOM CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 307. UNITED KINGDOM CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 308. UNITED KINGDOM CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 309. UNITED KINGDOM CORONARY ARTERY BYPASS GRAFTS MARKET S